期刊文献+

人脐带间充质干细胞在肝病治疗中的研究与应用 被引量:3

原文传递
导出
摘要 间充质干细胞(mesenchymal stem cell,MSC)是来源于发育早期中胚层的具有高度自我更新能力和多向分化潜能的多能干细胞,有独特的免疫调节作用,能够分化为肝细胞样细胞、成纤维细胞、成骨细胞、软骨细胞、脂肪细胞、肌原细胞以及神经外胚泡等。实验证明,MSC分化的肝细胞样细胞具有正常肝细胞功能。所以,MSC移植治疗肝病已成为国内外干细胞研究的热点。MSC可以从很多组织中获取,如骨髓、脂肪、肝脏组织、肌肉、羊水、胎盘、脐带、脐带血、牙髓等。
出处 《中华传染病杂志》 CAS CSCD 北大核心 2012年第11期702-704,共3页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献25

  • 1Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 2003,21: 105-110.
  • 2Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using hone marrow mesenchymal stem cells. Gastroenterology, 2008, 134:2111-2121,e1-3.
  • 3Zhang S, Chen L, Liu T, et al. Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation. TissueEng Part A, 2012,18,1352-1364.
  • 4Tsai PC, Fu TW, Chen YM, et al. The therapeutic potential of human umbilical mesenchymal stem cells from Whartonrs jelly in the treatment of rat liver fibrosis. Liver Transpl, 2009,15:484-495.
  • 5Zhang YN, Lie PC, Wei X. Differentiation of mesenchymal stromal ceils derived from umbilical cord Whartonrs jelly into hepatocyte-like cells. Cytotherapy, 2009,11 : 548-558.
  • 6Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol, 2012,27 Suppl 2 : 112-120.
  • 7周炳喜,郭俊贤,韩双印,张延瑞.脐带间充质干细胞移植治疗终末期肝硬化的疗效及安全性[J].中国组织工程研究与临床康复,2011,15(32):5987-5990. 被引量:8
  • 8Tipnis S, Viswanathan C, Majumdar AS. Immunosupp-ressive properties of human umbilical cord-derived mesen-chymal stem cells: role of B7-H1 and IDO. Immunol Cell Biol, 2010,88:795-806.
  • 9Zhou C, Yang B, Tian Y, et al. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol, 2011,272:33-38.
  • 10Spaggiari GM, Capobianco A, Abdelrazik H, et al. Mesenehymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood, 2008,111 : 1327-1333.

二级参考文献4

共引文献7

同被引文献65

  • 1张佳光,王永华,马君荣,黄丽青,石次国.血液灌注和血浆置换联合熊去氧胆酸治疗慢性重型肝炎疗效观察[J].中华临床感染病杂志,2013,6(1):41-42. 被引量:2
  • 2李春明,刘毅.人脂肪间充质干细胞冻存方法的改进[J].中国美容医学,2007,16(8):1026-1028. 被引量:4
  • 3陈杰,韩丽娜,孙新婷,等.胸腺肽α1辅助治疗慢性乙型重症肝炎合并自发性腹膜炎的疗效观察[C]//第二届全国病毒性肝炎慢性化重症化基础与临床研究进展学术会议论文集.杭州:中华临床感染病杂志社,2012:142.
  • 4王允亮,史瑞,刘丽娟,等.姜黄素改善非酒精性脂肪性肝炎细胞模型胰岛素抵抗及炎症的研究[C]//全国中医药博士生学术交流会暨第四届全国中医药博士生优秀论文颁奖会议论文集.北京:中华中医药杂志社,2013:1513-1515.
  • 5Salama H, Zekri AR, Medhat E, et al. Peripheral vein infusion of autologous mesenchymal stem cells in EgyptianHCV-positive patients with end stage liver disease[J]. Stem Cell Res Ther,2014,5(3) :70. DOI: 10. l186/scrt459.
  • 6Uccelli A, de Rosbo NK. The immunomodulatory function of mesenchymal stem cells: mode of action and pathways[J]. Ann N Y Aead Sei, 2015,1351:114-126. DOI 10. llll/nyas. 12815.
  • 7Volarevic V, Nurkovic J, Arsenijevic N, et al. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis [J]. Stem Cells, 2014,32 ( 11 ) : 2818-2823. DOI : 10. 1002/stem. 1818.
  • 8Herencia C, Almad4n Y, Martinez-Moreno JM,et al. Human mesenchymal stromal cell lysates as a novel strategy to recover liver function[J]. Regen Med, 2015,10 (1) : 25-38. DOI: 10. 2217/rme. 14.59.
  • 9Park M, Kim YH, Woo SY, et al. Tonsil-derived mesenchymal stem cells ameliorate CC14-induced liver fibrosis in mice via autophagy activation [J]. Sci Rep, 2015,5 : 8616 (2015-02-27) [2016-03-19]. http: //www. nature, com/articles/srep08616. DOI: 10. 1038/srep08616.
  • 10Gronthos S, Zannettino AC. A method to isolate and purify human bone marrow stromal stem cells [J]. Methods Mol Biol, 2008,449:45-57. DOI:10. 1007/978-1-60327-169-13.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部